SOLVSolventum
The financials
Solventum by the numbers
Solventum (SOLV) reported revenue of $1.95B in Q3 2026 (quarter ended Sep 30, 2026), down 7.0% from the same quarter a year earlier. That came with a gross margin of 54% and net loss of $12M. For the full year FY2025, revenue was $8.32B (+0.9% year on year) and net income $1.56B. Its largest segment in Q3 2026 was MedSurg at $528M, 44% of the disclosed total, ahead of Health Information Systems at 30%. The next results filing is expected around Feb 25, 2027, the same week as a year ago.
| Income statement | Q3 2026 | Q3 2025 | Change |
|---|---|---|---|
| Revenue | $1.95B | $2.10B | −7.0% |
| Gross profit | $1.06B | $1.14B | −6.4% |
| Operating income | $68M | $1.69B | −96% |
| Net income | −$12M | $1.27B | to a loss |
| Diluted EPS | −$0.07 | $7.22 | to a loss |
| Operating | Revenue | Share |
|---|---|---|
| MedSurg | $528M | 44% |
| Health Information Systems | $356M | 30% |
| Dental Solutions | $317M | 26% |
Over its last three fiscal years Solventum booked income tax of 15.2% of its pretax profit, 25.6% once deferred tax is taken out, below the 21.3% median for US companies in our tax study.
Business segments
Revenue split by operating segment, from SEC XBRL filings.
- MedSurg$528.0M$528.0Mvs last quarter -1.7%vs a year ago +8.9%-1.7%+8.9%
- Health Information Systems$356.0M$356.0Mvs last quarter +0.56%vs a year ago +3.2%+0.56%+3.2%
- Dental Solutions$317.0M$317.0Mvs last quarter -20%vs a year ago -6.8%-20%-6.8%
- Purification and Filtration$0.00$0.00vs last quarter n/avs a year ago -100%n/a-100%
Medical Instruments & Supplies
The closest names by size in the same industry